138 related articles for article (PubMed ID: 8778196)
1. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy.
Guido M; Rugge M; Chemello L; Leandro G; Fattovich G; Giustina G; Cassaro M; Alberti A
J Hepatol; 1996 Mar; 24(3):301-7. PubMed ID: 8778196
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
3. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment.
Jármay K; Gallai M; Karácsony G; Ozsvár Z; Schaff Z; Lonovics J; Kovalszky I
J Hepatol; 2000 Jun; 32(6):993-1002. PubMed ID: 10898320
[TBL] [Abstract][Full Text] [Related]
4. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
[TBL] [Abstract][Full Text] [Related]
6. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
7. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
8. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
9. Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation.
Shen H; Zhang M; Minuk GY; Gong Y
BMC Cell Biol; 2002 Apr; 3():9. PubMed ID: 11940252
[TBL] [Abstract][Full Text] [Related]
10. GFAP expression in the liver as an early marker of stellate cells activation.
Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.
Ramm GA; Crawford DH; Powell LW; Walker NI; Fletcher LM; Halliday JW
J Hepatol; 1997 Mar; 26(3):584-92. PubMed ID: 9075666
[TBL] [Abstract][Full Text] [Related]
12. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B.
Morimitsu Y; Kleiner DE; Conjeevaram HS; Hsia CC; Di Bisceglie AM; Tabor E
Hepatology; 1995 Oct; 22(4 Pt 1):1021-6. PubMed ID: 7557846
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C.
Chu CM; Shyu WC; Liaw YF
Dig Dis Sci; 2008 May; 53(5):1364-9. PubMed ID: 17934809
[TBL] [Abstract][Full Text] [Related]
17. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.
Houglum K; Venkataramani A; Lyche K; Chojkier M
Gastroenterology; 1997 Oct; 113(4):1069-73. PubMed ID: 9322499
[TBL] [Abstract][Full Text] [Related]
19. [A prospective study on histological and serological changes after interferon alpha-2b treatment in patients with chronic hepatitis B infection].
Lang Z; Zhao C; Xu D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):145-7. PubMed ID: 11517899
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
Baroni GS; D'Ambrosio L; Curto P; Casini A; Mancini R; Jezequel AM; Benedetti A
Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
